Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jul 12, 2022
- Accession no.
- 0001127602-22-019251
- Filed
- Jul 12, 2022
- Trade date
- Jul 8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $844.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | SSaleDisposed | −11,137 | $75.16 | −$837,056.92 | 524,274 | Direct | |
| Jul 8, 2022 | Common Stock | SSaleDisposed | −100 | $76.00 | −$7,600 | 524,174 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.